Press release
Genomics in Cancer Care Market Set for Breakthrough Growth with Precision Medicine Advancements 2025 | DataM Intelligence
Credits Image: https://www.technologynetworks.com
The Genomics In Cancer Care Market reached USD 13.4 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 51.1 billion by 2031. The Global Genomics in Cancer Care Market is expected to exhibit a CAGR of 18.9% during the forecast period 2024-2031.
Genomics In Cancer Care Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/genomics-in-cancer-care-market?sz
The Genomics in Cancer Care Market refers to the industry focused on utilizing genomic technologies to study cancer at the molecular level. It involves DNA sequencing, biomarker identification, and precision medicine approaches to enable early diagnosis, targeted therapies, and personalized treatment plans. This market supports advancements in oncology research, drug development, and patient care outcomes.
Industry News of USA and Japan:
USA:
In 2025, Certis Oncology Solutions launched two AI-enabled genomic technologies, including CertisAI, which correlates drug response with a tumor's unique gene expression signature to enhance drug efficacy predictions for cancer therapies. (March 2025)
The Genomics in Cancer Care Market in the USA is expanding rapidly with advancements in artificial intelligence and next-generation sequencing, enabling more personalized treatments and companion diagnostics to improve cancer care. (July 2025)
Japan:
On May 27, 2025, Illumina received regulatory approval in Japan for its TruSight Oncology Comprehensive genomic profiling test, aimed at expanding access to precision oncology by analyzing DNA and RNA variants from solid tumors to guide targeted therapy selection.
The Japanese government has continued efforts under the "Action Plan for Whole Genome Analysis 2022," focusing on cancer genomic medicine through collaborations involving the National Cancer Center, biobanks, whole-genome sequencing, and AI, to improve cancer diagnosis, treatment, and preventive medicine. (Last updated in 2025)
Key Players:
Roche Diagnostics
AstraZeneca PLC
Illumina, Inc
Affymetrix
Agilent Technologies
Cancer Genetics Inc.
Beckman Coulter Inc.
Bio-Rad Labs
Danaher Corporation
Sigma Aldrich Corporation (Merck KGaA).
Growth Forecast Projected:
The Global Genomics In Cancer Care Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Genomics In Cancer Care Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=genomics-in-cancer-care-market
Market Segmentation:
By Product: Instruments, Consumables, Services.
By Application: Diagnostics, Personalized Medicine, Drug Discovery & Development, Research.
By Technology: Genome Sequencing, PCR, Microarray, Nucleic Acid Extraction and Purification, Others.
By End User: Hospitals, Clinics, Ambulatory Surgical Centers.
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
Benefits of the Report:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.
➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/genomics-in-cancer-care-market
People Also Ask:
➠ What is the global sales, production, consumption, import, and export value of the Genomics In Cancer Care market?
➠ Who are the leading manufacturers in the global Genomics In Cancer Care industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?
➠ What opportunities and challenges do vendors in the global Genomics In Cancer Care industry face?
➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?
➠ What are the key factors and limitations affecting the growth of the Genomics In Cancer Care market?
➠ What are the various sales, marketing, and distribution channels in the global industry?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Genomics in Cancer Care Market Set for Breakthrough Growth with Precision Medicine Advancements 2025 | DataM Intelligence here
News-ID: 4168540 • Views: …
More Releases from DataM Intelligence 4Market Research
Saudi Arabia Laboratories Market Poised for Strong Growth Amid Rising Healthcare …
Market Size and Growth:
Saudi Arabia Laboratories Market size was valued at US$ 766.4 million in 2021 and is estimated to reach US$ million by 2029, growing at a CAGR of 7.3 % during the forecast period (2024-2031).
Saudi Arabia Laboratories Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
Interventional Cardiology and Peripheral Vascular Devices Market Set for Robust …
Market Size and Growth:
The Global Interventional Cardiology and Peripheral Vascular Devices Market reached US$ 20.11 billion in 2023, with a rise to US$ 21.58 billion in 2024, and is expected to reach US$ 41.17 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Interventional Cardiology and Peripheral Vascular Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities,…
Cardiac Monitoring Devices Market Surges with Rising Heart Disease Cases & AI-Dr …
Market Size and Growth:
The Cardiac Monitoring Devices Market size was valued at USD 7,696.50 million in 2021 and is estimated to reach a compound annual growth rate (CAGR) of 5.90% over the forecast period 2024-2031.
Cardiac Monitoring Devices Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions…
Global Dental Crowns and Bridges Market Poised for Robust Growth Driven by Risin …
Market Size and Growth:
The Dental Crowns and Bridges Market size was valued at USD 3,840.30 million in 2021 and is estimated to reach a compound annual growth rate (CAGR) of 7.30% over the forecast period 2024-2031.
Dental Crowns and Bridges Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
